Evren I - Search Results

1

Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation.

Wils LJ, Poell JB, Brink A, Evren I, Brouns ER, de Visscher JGAM, Bloemena E, Brakenhoff RH. Wils LJ, et al. Among authors: evren i. Clin Cancer Res. 2023 Feb 1;29(3):602-613. doi: 10.1158/1078-0432.CCR-22-2210. Clin Cancer Res. 2023. PMID: 36449687

2

Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.

Wils LJ, Poell JB, Evren I, Koopman MS, Brouns EREA, de Visscher JGAM, Brakenhoff RH, Bloemena E. Wils LJ, et al. Among authors: evren i. Mod Pathol. 2020 Jun;33(6):1033-1040. doi: 10.1038/s41379-019-0444-0. Epub 2020 Jan 2. Mod Pathol. 2020. PMID: 31896811 Free PMC article.

3

Annual malignant transformation rate of oral leukoplakia remains consistent: A long-term follow-up study.

Evren I, Brouns ER, Wils LJ, Poell JB, Peeters CFW, Brakenhoff RH, Bloemena E, de Visscher JGAM. Evren I, et al. Oral Oncol. 2020 Nov;110:105014. doi: 10.1016/j.oraloncology.2020.105014. Epub 2020 Oct 7. Oral Oncol. 2020. PMID: 33038723

4

[Identification of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression].

Wils LJ, Poell JB, Evren I, Koopman MS, Brouns EREA, de Visscher JGAM, Brakenhoff RH, Bloemena E. Wils LJ, et al. Among authors: evren i. Ned Tijdschr Tandheelkd. 2021 Feb;128(2):103-111. doi: 10.5177/ntvt.2021.02.20078. Ned Tijdschr Tandheelkd. 2021. PMID: 33605260 Dutch.

5

Associations between clinical and histopathological characteristics in oral leukoplakia.

Evren I, Brouns ER, Poell JB, Wils LJ, Brakenhoff RH, Bloemena E, de Visscher JGAM. Evren I, et al. Oral Dis. 2023 Mar;29(2):696-706. doi: 10.1111/odi.14038. Epub 2021 Oct 14. Oral Dis. 2023. PMID: 34601770 Free PMC article.

6

Oral leukoplakia classification and staging system with incorporation of differentiated dysplasia.

Brouns ER, Evren I, Wils LJ, Poell JB, Brakenhoff RH, Bloemena E, de Visscher JGAM. Brouns ER, et al. Among authors: evren i. Oral Dis. 2023 Oct;29(7):2667-2676. doi: 10.1111/odi.14295. Epub 2022 Jul 7. Oral Dis. 2023. PMID: 35765231

7

Oral cancer prediction by noninvasive genetic screening.

Poell JB, Wils LJ, Brink A, Dietrich R, Krieg C, Velleuer E, Evren I, Brouns ER, de Visscher JG, Bloemena E, Ylstra B, Brakenhoff RH. Poell JB, et al. Among authors: evren i. Int J Cancer. 2023 Jan 15;152(2):227-238. doi: 10.1002/ijc.34277. Epub 2022 Sep 18. Int J Cancer. 2023. PMID: 36069231 Free PMC article.

8

The role of differentiated dysplasia in the prediction of malignant transformation of oral leukoplakia.

Wils LJ, Poell JB, Peferoen LAN, Evren I, Brouns ER, de Visscher JGAM, van der Meij EH, Brakenhoff RH, Bloemena E. Wils LJ, et al. Among authors: evren i. J Oral Pathol Med. 2023 Nov;52(10):930-938. doi: 10.1111/jop.13483. Epub 2023 Sep 25. J Oral Pathol Med. 2023. PMID: 37749621

9

The value of regular follow-up of oral leukoplakia for early detection of malignant transformation.

Evren I, Najim AM, Poell JB, Brouns ER, Wils LJ, Peferoen LAN, Brakenhoff RH, Bloemena E, van der Meij EH, de Visscher JGAM. Evren I, et al. Oral Dis. 2023 Nov 7. doi: 10.1111/odi.14797. Online ahead of print. Oral Dis. 2023. PMID: 37936517

10

Outcome expectation and risk tolerance in patients seeking bariatric surgery.

van Rijswijk AS, Evren I, Geubbels N, Hutten BA, Acherman YIZ, van der Peet DL, Bruin SC. van Rijswijk AS, et al. Among authors: evren i. Surg Obes Relat Dis. 2021 Jan;17(1):139-146. doi: 10.1016/j.soard.2020.08.020. Epub 2020 Aug 25. Surg Obes Relat Dis. 2021. PMID: 33067137

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page